> top > docs > PubMed:19048115 > annotations

PubMed:19048115 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-109 Sentence denotes Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations.
T2 110-220 Sentence denotes Ovarian serous carcinoma (OSC) is the most common and lethal histologic type of ovarian epithelial malignancy.
T3 221-492 Sentence denotes Mutations of TP53 and dysfunction of the Brca1 and/or Brca2 tumor-suppressor proteins have been implicated in the molecular pathogenesis of a large fraction of OSCs, but frequent somatic mutations in other well-established tumor-suppressor genes have not been identified.
T4 493-647 Sentence denotes Using a genome-wide screen of DNA copy number alterations in 36 primary OSCs, we identified two tumors with apparent homozygous deletions of the NF1 gene.
T5 648-757 Sentence denotes Subsequently, 18 ovarian carcinoma-derived cell lines and 41 primary OSCs were evaluated for NF1 alterations.
T6 758-1085 Sentence denotes Markedly reduced or absent expression of Nf1 protein was observed in 6 of the 18 cell lines, and using the protein truncation test and sequencing of cDNA and genomic DNA, NF1 mutations resulting in deletion of exons and/or aberrant splicing of NF1 transcripts were detected in 5 of the 6 cell lines with loss of NF1 expression.
T7 1086-1213 Sentence denotes Similarly, NF1 alterations including homozygous deletions and splicing mutations were identified in 9 (22%) of 41 primary OSCs.
T8 1214-1462 Sentence denotes As expected, tumors and cell lines with NF1 defects lacked mutations in KRAS or BRAF but showed Ras pathway activation based on immunohistochemical detection of phosphorylated MAPK (primary tumors) or increased levels of GTP-bound Ras (cell lines).
T9 1463-1711 Sentence denotes The TP53 tumor-suppressor gene was mutated in all OSCs with documented NF1 mutation, suggesting that the pathways regulated by these two tumor-suppressor proteins often cooperate in the development of ovarian carcinomas with serous differentiation.

LitCoin-entities-OrganismTaxon-PD

Id Subject Object Predicate Lexical cue db_id
T1 44-49 OrganismTaxon denotes human NCBItxid:9606

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
5551 0-15 GeneOrGeneProduct denotes Neurofibromin 1 NCBIGene:4763
5552 17-20 GeneOrGeneProduct denotes NF1 NCBIGene:4763
5553 44-49 OrganismTaxon denotes human NCBITaxon:9606
5554 50-75 DiseaseOrPhenotypicFeature denotes ovarian serous carcinomas MESH:D010051
5555 94-98 GeneOrGeneProduct denotes TP53 NCBIGene:7157
5556 110-134 DiseaseOrPhenotypicFeature denotes Ovarian serous carcinoma MESH:D010051
5557 136-139 DiseaseOrPhenotypicFeature denotes OSC MESH:D010051
5558 190-219 DiseaseOrPhenotypicFeature denotes ovarian epithelial malignancy MESH:D002277
5559 234-238 GeneOrGeneProduct denotes TP53 NCBIGene:7157
5560 262-267 GeneOrGeneProduct denotes Brca1 NCBIGene:672
5561 275-280 GeneOrGeneProduct denotes Brca2 NCBIGene:675
5562 281-286 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
5563 381-385 DiseaseOrPhenotypicFeature denotes OSCs MESH:D010051
5564 444-449 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
5565 565-569 DiseaseOrPhenotypicFeature denotes OSCs MESH:D010051
5566 589-595 DiseaseOrPhenotypicFeature denotes tumors MESH:D009369
5567 638-641 GeneOrGeneProduct denotes NF1 NCBIGene:4763
5568 665-682 DiseaseOrPhenotypicFeature denotes ovarian carcinoma MESH:D010051
5569 717-721 DiseaseOrPhenotypicFeature denotes OSCs MESH:D010051
5570 741-744 GeneOrGeneProduct denotes NF1 NCBIGene:4763
5571 799-802 GeneOrGeneProduct denotes Nf1 NCBIGene:4763
5572 929-932 GeneOrGeneProduct denotes NF1 NCBIGene:4763
5573 1002-1005 GeneOrGeneProduct denotes NF1 NCBIGene:4763
5574 1070-1073 GeneOrGeneProduct denotes NF1 NCBIGene:4763
5575 1097-1100 GeneOrGeneProduct denotes NF1 NCBIGene:4763
5576 1208-1212 DiseaseOrPhenotypicFeature denotes OSCs MESH:D010051
5577 1227-1233 DiseaseOrPhenotypicFeature denotes tumors MESH:D009369
5578 1254-1257 GeneOrGeneProduct denotes NF1 NCBIGene:4763
5579 1286-1290 GeneOrGeneProduct denotes KRAS NCBIGene:3845
5580 1294-1298 GeneOrGeneProduct denotes BRAF NCBIGene:673
5581 1310-1313 GeneOrGeneProduct denotes Ras NCBIGene:3845
5582 1390-1394 GeneOrGeneProduct denotes MAPK NCBIGene:5594
5583 1404-1410 DiseaseOrPhenotypicFeature denotes tumors MESH:D009369
5584 1435-1438 ChemicalEntity denotes GTP MESH:D006160
5585 1445-1448 GeneOrGeneProduct denotes Ras NCBIGene:3845
5586 1467-1471 GeneOrGeneProduct denotes TP53 NCBIGene:7157
5587 1472-1477 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
5588 1513-1517 DiseaseOrPhenotypicFeature denotes OSCs MESH:D010051
5589 1534-1537 GeneOrGeneProduct denotes NF1 NCBIGene:4763
5590 1600-1605 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
5591 1664-1682 DiseaseOrPhenotypicFeature denotes ovarian carcinomas MESH:D010051

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 65-75 DiseaseOrPhenotypicFeature denotes carcinomas 0004993
T2 125-134 DiseaseOrPhenotypicFeature denotes carcinoma 0004993
T3 665-682 DiseaseOrPhenotypicFeature denotes ovarian carcinoma 0005140
T4 673-682 DiseaseOrPhenotypicFeature denotes carcinoma 0004993
T5 1664-1682 DiseaseOrPhenotypicFeature denotes ovarian carcinomas 0005140

LitCoin-SeqVar

Id Subject Object Predicate Lexical cue
T1 956-973 SequenceVariant denotes deletion of exons

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 0-15 GeneOrGeneProduct denotes Neurofibromin 1
T2 17-20 GeneOrGeneProduct denotes NF1
T3 22-33 GeneOrGeneProduct denotes defects are
T4 94-98 GeneOrGeneProduct denotes TP53
T5 99-108 GeneOrGeneProduct denotes mutations
T6 136-139 GeneOrGeneProduct denotes OSC
T7 164-170 GeneOrGeneProduct denotes lethal
T8 221-230 GeneOrGeneProduct denotes Mutations
T9 234-238 GeneOrGeneProduct denotes TP53
T10 262-267 GeneOrGeneProduct denotes Brca1
T11 275-280 GeneOrGeneProduct denotes Brca2
T12 287-297 GeneOrGeneProduct denotes suppressor
T13 298-306 GeneOrGeneProduct denotes proteins
T14 363-368 GeneOrGeneProduct denotes large
T15 381-385 GeneOrGeneProduct denotes OSCs
T16 408-417 GeneOrGeneProduct denotes mutations
T17 421-426 GeneOrGeneProduct denotes other
T18 450-460 GeneOrGeneProduct denotes suppressor
T19 551-556 GeneOrGeneProduct denotes in 36
T20 565-569 GeneOrGeneProduct denotes OSCs
T21 589-595 GeneOrGeneProduct denotes tumors
T22 638-641 GeneOrGeneProduct denotes NF1
T23 691-695 GeneOrGeneProduct denotes cell
T24 696-701 GeneOrGeneProduct denotes lines
T25 717-721 GeneOrGeneProduct denotes OSCs
T26 741-744 GeneOrGeneProduct denotes NF1
T27 758-766 GeneOrGeneProduct denotes Markedly
T28 767-774 GeneOrGeneProduct denotes reduced
T29 803-810 GeneOrGeneProduct denotes protein
T30 824-828 GeneOrGeneProduct denotes in 6
T31 839-843 GeneOrGeneProduct denotes cell
T32 844-849 GeneOrGeneProduct denotes lines
T33 865-872 GeneOrGeneProduct denotes protein
T34 873-883 GeneOrGeneProduct denotes truncation
T35 884-888 GeneOrGeneProduct denotes test
T36 907-911 GeneOrGeneProduct denotes cDNA
T37 929-932 GeneOrGeneProduct denotes NF1
T38 933-942 GeneOrGeneProduct denotes mutations
T39 990-998 GeneOrGeneProduct denotes splicing
T40 1002-1005 GeneOrGeneProduct denotes NF1
T41 1006-1017 GeneOrGeneProduct denotes transcripts
T42 1032-1036 GeneOrGeneProduct denotes in 5
T43 1046-1050 GeneOrGeneProduct denotes cell
T44 1051-1056 GeneOrGeneProduct denotes lines
T45 1070-1073 GeneOrGeneProduct denotes NF1
T46 1086-1095 GeneOrGeneProduct denotes Similarly
T47 1097-1100 GeneOrGeneProduct denotes NF1
T48 1148-1156 GeneOrGeneProduct denotes splicing
T49 1157-1166 GeneOrGeneProduct denotes mutations
T50 1183-1187 GeneOrGeneProduct denotes in 9
T51 1208-1212 GeneOrGeneProduct denotes OSCs
T52 1227-1233 GeneOrGeneProduct denotes tumors
T53 1238-1242 GeneOrGeneProduct denotes cell
T54 1243-1248 GeneOrGeneProduct denotes lines
T55 1254-1257 GeneOrGeneProduct denotes NF1
T56 1258-1265 GeneOrGeneProduct denotes defects
T57 1266-1272 GeneOrGeneProduct denotes lacked
T58 1273-1282 GeneOrGeneProduct denotes mutations
T59 1286-1290 GeneOrGeneProduct denotes KRAS
T60 1294-1298 GeneOrGeneProduct denotes BRAF
T61 1322-1332 GeneOrGeneProduct denotes activation
T62 1333-1338 GeneOrGeneProduct denotes based
T63 1390-1394 GeneOrGeneProduct denotes MAPK
T64 1404-1410 GeneOrGeneProduct denotes tumors
T65 1450-1454 GeneOrGeneProduct denotes cell
T66 1455-1460 GeneOrGeneProduct denotes lines
T67 1467-1471 GeneOrGeneProduct denotes TP53
T68 1478-1488 GeneOrGeneProduct denotes suppressor
T69 1498-1505 GeneOrGeneProduct denotes mutated
T70 1509-1512 GeneOrGeneProduct denotes all
T71 1513-1517 GeneOrGeneProduct denotes OSCs
T72 1534-1537 GeneOrGeneProduct denotes NF1
T73 1538-1546 GeneOrGeneProduct denotes mutation
T74 1577-1586 GeneOrGeneProduct denotes regulated
T75 1606-1616 GeneOrGeneProduct denotes suppressor
T76 1617-1625 GeneOrGeneProduct denotes proteins

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 0-15 GeneOrGeneProduct denotes Neurofibromin 1
T2 17-20 GeneOrGeneProduct denotes NF1
T3 94-98 GeneOrGeneProduct denotes TP53
T4 136-139 GeneOrGeneProduct denotes OSC
T5 164-170 GeneOrGeneProduct denotes lethal
T6 234-238 GeneOrGeneProduct denotes TP53
T7 262-267 GeneOrGeneProduct denotes Brca1
T8 275-280 GeneOrGeneProduct denotes Brca2
T9 287-297 GeneOrGeneProduct denotes suppressor
T10 363-368 GeneOrGeneProduct denotes large
T11 421-426 GeneOrGeneProduct denotes other
T12 450-460 GeneOrGeneProduct denotes suppressor
T13 638-641 GeneOrGeneProduct denotes NF1
T14 691-695 GeneOrGeneProduct denotes cell
T15 696-701 GeneOrGeneProduct denotes lines
T16 741-744 GeneOrGeneProduct denotes NF1
T17 767-774 GeneOrGeneProduct denotes reduced
T18 803-810 GeneOrGeneProduct denotes protein
T19 839-843 GeneOrGeneProduct denotes cell
T20 844-849 GeneOrGeneProduct denotes lines
T21 865-872 GeneOrGeneProduct denotes protein
T22 907-911 GeneOrGeneProduct denotes cDNA
T23 929-932 GeneOrGeneProduct denotes NF1
T24 1002-1005 GeneOrGeneProduct denotes NF1
T25 1046-1050 GeneOrGeneProduct denotes cell
T26 1051-1056 GeneOrGeneProduct denotes lines
T27 1070-1073 GeneOrGeneProduct denotes NF1
T28 1097-1100 GeneOrGeneProduct denotes NF1
T29 1238-1242 GeneOrGeneProduct denotes cell
T30 1243-1248 GeneOrGeneProduct denotes lines
T31 1254-1257 GeneOrGeneProduct denotes NF1
T32 1286-1290 GeneOrGeneProduct denotes KRAS
T33 1294-1298 GeneOrGeneProduct denotes BRAF
T34 1390-1394 GeneOrGeneProduct denotes MAPK
T35 1450-1454 GeneOrGeneProduct denotes cell
T36 1455-1460 GeneOrGeneProduct denotes lines
T37 1467-1471 GeneOrGeneProduct denotes TP53
T38 1478-1488 GeneOrGeneProduct denotes suppressor
T39 1534-1537 GeneOrGeneProduct denotes NF1
T40 1606-1616 GeneOrGeneProduct denotes suppressor

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 65-75 DiseaseOrPhenotypicFeature denotes carcinomas D002277
T2 125-134 DiseaseOrPhenotypicFeature denotes carcinoma D002277
T3 209-219 DiseaseOrPhenotypicFeature denotes malignancy D009369
T4 281-286 DiseaseOrPhenotypicFeature denotes tumor D009369
T5 444-449 DiseaseOrPhenotypicFeature denotes tumor D009369
T6 589-595 DiseaseOrPhenotypicFeature denotes tumors D009369
T7 673-682 DiseaseOrPhenotypicFeature denotes carcinoma D002277
T8 1227-1233 DiseaseOrPhenotypicFeature denotes tumors D009369
T9 1404-1410 DiseaseOrPhenotypicFeature denotes tumors D009369
T10 1472-1477 DiseaseOrPhenotypicFeature denotes tumor D009369
T11 1600-1605 DiseaseOrPhenotypicFeature denotes tumor D009369
T12 1672-1682 DiseaseOrPhenotypicFeature denotes carcinomas D002277

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 0-15 GeneOrGeneProduct denotes Neurofibromin 1
T2 17-20 GeneOrGeneProduct denotes NF1
T3 94-98 GeneOrGeneProduct denotes TP53
T4 136-139 GeneOrGeneProduct denotes OSC
T5 234-238 GeneOrGeneProduct denotes TP53
T6 275-280 GeneOrGeneProduct denotes Brca2
T7 287-306 GeneOrGeneProduct denotes suppressor proteins
T8 450-460 GeneOrGeneProduct denotes suppressor
T9 638-641 GeneOrGeneProduct denotes NF1
T10 741-744 GeneOrGeneProduct denotes NF1
T11 799-810 GeneOrGeneProduct denotes Nf1 protein
T12 929-932 GeneOrGeneProduct denotes NF1
T13 1002-1005 GeneOrGeneProduct denotes NF1
T14 1070-1073 GeneOrGeneProduct denotes NF1
T15 1097-1100 GeneOrGeneProduct denotes NF1
T16 1254-1257 GeneOrGeneProduct denotes NF1
T17 1286-1290 GeneOrGeneProduct denotes KRAS
T18 1294-1298 GeneOrGeneProduct denotes BRAF
T19 1390-1394 GeneOrGeneProduct denotes MAPK
T20 1467-1471 GeneOrGeneProduct denotes TP53
T21 1478-1488 GeneOrGeneProduct denotes suppressor
T22 1534-1537 GeneOrGeneProduct denotes NF1
T23 1606-1625 GeneOrGeneProduct denotes suppressor proteins

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 17-20 DiseaseOrPhenotypicFeature denotes NF1 0018975
T2 50-75 DiseaseOrPhenotypicFeature denotes ovarian serous carcinomas 0005211
T3 110-134 DiseaseOrPhenotypicFeature denotes Ovarian serous carcinoma 0005211
T4 136-139 DiseaseOrPhenotypicFeature denotes OSC 0005211
T5 209-219 DiseaseOrPhenotypicFeature denotes malignancy 0004992
T6 281-286 DiseaseOrPhenotypicFeature denotes tumor 0005070
T7 444-449 DiseaseOrPhenotypicFeature denotes tumor 0005070
T8 638-641 DiseaseOrPhenotypicFeature denotes NF1 0018975
T9 665-682 DiseaseOrPhenotypicFeature denotes ovarian carcinoma 0005140
T10 741-744 DiseaseOrPhenotypicFeature denotes NF1 0018975
T11 929-932 DiseaseOrPhenotypicFeature denotes NF1 0018975
T12 1002-1005 DiseaseOrPhenotypicFeature denotes NF1 0018975
T13 1070-1073 DiseaseOrPhenotypicFeature denotes NF1 0018975
T14 1097-1100 DiseaseOrPhenotypicFeature denotes NF1 0018975
T15 1254-1257 DiseaseOrPhenotypicFeature denotes NF1 0018975
T16 1472-1477 DiseaseOrPhenotypicFeature denotes tumor 0005070
T17 1534-1537 DiseaseOrPhenotypicFeature denotes NF1 0018975
T18 1600-1605 DiseaseOrPhenotypicFeature denotes tumor 0005070
T19 1664-1682 DiseaseOrPhenotypicFeature denotes ovarian carcinomas 0005140

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 65-75 DiseaseOrPhenotypicFeature denotes carcinomas D002277
T2 125-134 DiseaseOrPhenotypicFeature denotes carcinoma D002277
T3 136-139 DiseaseOrPhenotypicFeature denotes OSC DISEASE
T4 209-219 DiseaseOrPhenotypicFeature denotes malignancy D009369
T5 281-286 DiseaseOrPhenotypicFeature denotes tumor D009369
T6 381-385 DiseaseOrPhenotypicFeature denotes OSCs DISEASE
T7 444-449 DiseaseOrPhenotypicFeature denotes tumor D009369
T8 565-569 DiseaseOrPhenotypicFeature denotes OSCs DISEASE
T9 589-595 DiseaseOrPhenotypicFeature denotes tumors DISEASE|D009369
T11 673-682 DiseaseOrPhenotypicFeature denotes carcinoma D002277
T12 717-721 DiseaseOrPhenotypicFeature denotes OSCs DISEASE
T13 1208-1212 DiseaseOrPhenotypicFeature denotes OSCs DISEASE
T14 1227-1233 DiseaseOrPhenotypicFeature denotes tumors DISEASE|D009369
T16 1404-1410 DiseaseOrPhenotypicFeature denotes tumors DISEASE|D009369
T18 1472-1477 DiseaseOrPhenotypicFeature denotes tumor D009369
T19 1513-1517 DiseaseOrPhenotypicFeature denotes OSCs DISEASE
T20 1600-1605 DiseaseOrPhenotypicFeature denotes tumor D009369
T21 1672-1682 DiseaseOrPhenotypicFeature denotes carcinomas D002277

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 65-75 DiseaseOrPhenotypicFeature denotes carcinomas D002277
T2 125-134 DiseaseOrPhenotypicFeature denotes carcinoma D002277
T3 136-139 DiseaseOrPhenotypicFeature denotes OSC DISEASE
T4 209-219 DiseaseOrPhenotypicFeature denotes malignancy D009369
T5 281-286 DiseaseOrPhenotypicFeature denotes tumor D009369
T6 381-385 DiseaseOrPhenotypicFeature denotes OSCs DISEASE
T7 444-449 DiseaseOrPhenotypicFeature denotes tumor D009369
T8 565-569 DiseaseOrPhenotypicFeature denotes OSCs DISEASE
T9 589-595 DiseaseOrPhenotypicFeature denotes tumors D009369
T10 673-682 DiseaseOrPhenotypicFeature denotes carcinoma D002277
T11 717-721 DiseaseOrPhenotypicFeature denotes OSCs DISEASE
T12 1208-1212 DiseaseOrPhenotypicFeature denotes OSCs DISEASE
T13 1227-1233 DiseaseOrPhenotypicFeature denotes tumors D009369
T14 1404-1410 DiseaseOrPhenotypicFeature denotes tumors D009369
T15 1472-1477 DiseaseOrPhenotypicFeature denotes tumor D009369
T16 1513-1517 DiseaseOrPhenotypicFeature denotes OSCs DISEASE
T17 1600-1605 DiseaseOrPhenotypicFeature denotes tumor D009369
T18 1672-1682 DiseaseOrPhenotypicFeature denotes carcinomas D002277

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 44-49 OrganismTaxon denotes human

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 1435-1438 ChemicalEntity denotes GTP http://purl.obolibrary.org/obo/CHEBI_37565|http://purl.obolibrary.org/obo/CHEBI_15996

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T1 1435-1438 ChemicalEntity denotes GTP http://purl.obolibrary.org/obo/CHEBI_15996|http://purl.obolibrary.org/obo/CHEBI_37565
T23 1606-1625 GeneOrGeneProduct denotes suppressor proteins
T22 1534-1537 GeneOrGeneProduct denotes NF1
T21 1478-1488 GeneOrGeneProduct denotes suppressor
T20 1467-1471 GeneOrGeneProduct denotes TP53
T19 1390-1394 GeneOrGeneProduct denotes MAPK
T18 1294-1298 GeneOrGeneProduct denotes BRAF
T17 1286-1290 GeneOrGeneProduct denotes KRAS
T16 1254-1257 GeneOrGeneProduct denotes NF1
T15 1097-1100 GeneOrGeneProduct denotes NF1
T14 1070-1073 GeneOrGeneProduct denotes NF1
T13 1002-1005 GeneOrGeneProduct denotes NF1
T12 929-932 GeneOrGeneProduct denotes NF1
T11 799-810 GeneOrGeneProduct denotes Nf1 protein
T10 741-744 GeneOrGeneProduct denotes NF1
T9 638-641 GeneOrGeneProduct denotes NF1
T8 450-460 GeneOrGeneProduct denotes suppressor
T7 287-306 GeneOrGeneProduct denotes suppressor proteins
T6 275-280 GeneOrGeneProduct denotes Brca2
T5 234-238 GeneOrGeneProduct denotes TP53
T4 136-139 GeneOrGeneProduct denotes OSC
T3 94-98 GeneOrGeneProduct denotes TP53
T2 17-20 GeneOrGeneProduct denotes NF1
T7660 0-15 GeneOrGeneProduct denotes Neurofibromin 1
T47876 1672-1682 DiseaseOrPhenotypicFeature denotes carcinomas D002277
T46834 1600-1605 DiseaseOrPhenotypicFeature denotes tumor D009369
T97850 1513-1517 DiseaseOrPhenotypicFeature denotes OSCs DISEASE
T720 1472-1477 DiseaseOrPhenotypicFeature denotes tumor D009369
T50555 1404-1410 DiseaseOrPhenotypicFeature denotes tumors D009369
T53594 1227-1233 DiseaseOrPhenotypicFeature denotes tumors D009369
T95800 1208-1212 DiseaseOrPhenotypicFeature denotes OSCs DISEASE
T72726 717-721 DiseaseOrPhenotypicFeature denotes OSCs DISEASE
T27292 673-682 DiseaseOrPhenotypicFeature denotes carcinoma D002277
T86660 589-595 DiseaseOrPhenotypicFeature denotes tumors D009369
T20393 565-569 DiseaseOrPhenotypicFeature denotes OSCs DISEASE
T58509 444-449 DiseaseOrPhenotypicFeature denotes tumor D009369
T32450 381-385 DiseaseOrPhenotypicFeature denotes OSCs DISEASE
T39735 281-286 DiseaseOrPhenotypicFeature denotes tumor D009369
T43052 209-219 DiseaseOrPhenotypicFeature denotes malignancy D009369
T10879 136-139 DiseaseOrPhenotypicFeature denotes OSC DISEASE
T69314 125-134 DiseaseOrPhenotypicFeature denotes carcinoma D002277
T67918 65-75 DiseaseOrPhenotypicFeature denotes carcinomas D002277
T37895 44-49 OrganismTaxon denotes human
T76840 956-973 SequenceVariant denotes deletion of exons

PMID_GLOBAL

Id Subject Object Predicate Lexical cue mondo_id
T1 17-20 DiseaseOrPhenotypicFeature denotes NF1 0018975
T2 50-75 DiseaseOrPhenotypicFeature denotes ovarian serous carcinomas 0005211
T3 110-134 DiseaseOrPhenotypicFeature denotes Ovarian serous carcinoma 0005211
T4 136-139 DiseaseOrPhenotypicFeature denotes OSC 0005211
T5 209-219 DiseaseOrPhenotypicFeature denotes malignancy 0004992
T6 281-286 DiseaseOrPhenotypicFeature denotes tumor 0005070
T7 444-449 DiseaseOrPhenotypicFeature denotes tumor 0005070
T8 638-641 DiseaseOrPhenotypicFeature denotes NF1 0018975
T9 665-682 DiseaseOrPhenotypicFeature denotes ovarian carcinoma 0005140
T10 741-744 DiseaseOrPhenotypicFeature denotes NF1 0018975
T11 929-932 DiseaseOrPhenotypicFeature denotes NF1 0018975
T12 1002-1005 DiseaseOrPhenotypicFeature denotes NF1 0018975
T13 1070-1073 DiseaseOrPhenotypicFeature denotes NF1 0018975
T14 1097-1100 DiseaseOrPhenotypicFeature denotes NF1 0018975
T15 1254-1257 DiseaseOrPhenotypicFeature denotes NF1 0018975
T16 1472-1477 DiseaseOrPhenotypicFeature denotes tumor 0005070
T17 1534-1537 DiseaseOrPhenotypicFeature denotes NF1 0018975
T18 1600-1605 DiseaseOrPhenotypicFeature denotes tumor 0005070
T19 1664-1682 DiseaseOrPhenotypicFeature denotes ovarian carcinomas 0005140

DisGeNET

Id Subject Object Predicate Lexical cue
T0 1534-1537 gene:4763 denotes NF1
T1 1664-1682 disease:C0029925 denotes ovarian carcinomas
R1 T0 T1 associated_with NF1,ovarian carcinomas

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
19048115-2#13#17#gene7157 234-238 gene7157 denotes TP53
19048115-2#41#46#gene672 262-267 gene672 denotes Brca1
19048115-2#22#33#diseaseC3887505 243-254 diseaseC3887505 denotes dysfunction
19048115-2#160#163#diseaseC1335177 381-384 diseaseC1335177 denotes OSC
19048115-2#22#33#diseaseC3887505 243-254 diseaseC3887505 denotes dysfunction
19048115-2#160#163#diseaseC1335177 381-384 diseaseC1335177 denotes OSC
19048115-4#93#96#gene4763 741-744 gene4763 denotes NF1
19048115-4#17#34#diseaseC0677886 665-682 diseaseC0677886 denotes ovarian carcinoma
19048115-8#71#74#gene4763 1534-1537 gene4763 denotes NF1
19048115-8#50#53#diseaseC1335177 1513-1516 diseaseC1335177 denotes OSC
19048115-8#201#219#diseaseC0029925 1664-1682 diseaseC0029925 denotes ovarian carcinomas
13#17#gene715722#33#diseaseC3887505 19048115-2#13#17#gene7157 19048115-2#22#33#diseaseC3887505 associated_with TP53,dysfunction
13#17#gene7157160#163#diseaseC1335177 19048115-2#13#17#gene7157 19048115-2#160#163#diseaseC1335177 associated_with TP53,OSC
13#17#gene715722#33#diseaseC3887505 19048115-2#13#17#gene7157 19048115-2#22#33#diseaseC3887505 associated_with TP53,dysfunction
13#17#gene7157160#163#diseaseC1335177 19048115-2#13#17#gene7157 19048115-2#160#163#diseaseC1335177 associated_with TP53,OSC
41#46#gene67222#33#diseaseC3887505 19048115-2#41#46#gene672 19048115-2#22#33#diseaseC3887505 associated_with Brca1,dysfunction
41#46#gene672160#163#diseaseC1335177 19048115-2#41#46#gene672 19048115-2#160#163#diseaseC1335177 associated_with Brca1,OSC
41#46#gene67222#33#diseaseC3887505 19048115-2#41#46#gene672 19048115-2#22#33#diseaseC3887505 associated_with Brca1,dysfunction
41#46#gene672160#163#diseaseC1335177 19048115-2#41#46#gene672 19048115-2#160#163#diseaseC1335177 associated_with Brca1,OSC
93#96#gene476317#34#diseaseC0677886 19048115-4#93#96#gene4763 19048115-4#17#34#diseaseC0677886 associated_with NF1,ovarian carcinoma
71#74#gene476350#53#diseaseC1335177 19048115-8#71#74#gene4763 19048115-8#50#53#diseaseC1335177 associated_with NF1,OSC
71#74#gene4763201#219#diseaseC0029925 19048115-8#71#74#gene4763 19048115-8#201#219#diseaseC0029925 associated_with NF1,ovarian carcinomas

CoMAGC

Id Subject Object Predicate Lexical cue
T1 0-15 Gene denotes Neurofibromin 1
E2 22-29 Negative_regulation denotes defects
T2 50-75 ovarian cancer denotes ovarian serous carcinomas
R1 T1 E2 themeOf Neurofibromin 1,defects
R3 T1 T2 CGE-decreased Neurofibromin 1,ovarian serous carcinomas
R4 T1 T2 CCS-normalTOcancer Neurofibromin 1,ovarian serous carcinomas
R5 T1 T2 PT-observation Neurofibromin 1,ovarian serous carcinomas
R3 T1 T2 IGE-unchanged Neurofibromin 1,ovarian serous carcinomas